Search Results - "Pandya, Hetal"

Refine Results
  1. 1

    Differentiation of human and murine induced pluripotent stem cells to microglia-like cells by Pandya, Hetal, Shen, Michael J, Ichikawa, David M, Sedlock, Andrea B, Choi, Yong, Johnson, Kory R, Kim, Gloria, Brown, Mason A, Elkahloun, Abdel G, Maric, Dragan, Sweeney, Colin L, Gossa, Selamawit, Malech, Harry L, McGavern, Dorian B, Park, John K

    Published in Nature neuroscience (01-05-2017)
    “…Pandya et al . describe a protocol to differentiate human and mouse iPSCs into cells with the phenotype, transcriptional profile and functional properties of…”
    Get full text
    Journal Article
  2. 2

    Drosophila Heartless acts with Heartbroken/Dof in muscle founder differentiation by Dutta, Devkanya, Shaw, Sanjeev, Maqbool, Tariq, Pandya, Hetal, Vijayraghavan, K

    Published in PLoS biology (01-10-2005)
    “…The formation of a multi-nucleate myofibre is directed, in Drosophila, by a founder cell. In the embryo, founders are selected by Notch-mediated lateral…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Internet of things: Survey and case studies by Pandya, Hetal B, Champaneria, Tushar A

    “…The "Internet of Things" is a modern paradigm that foresees the near future of internet, which will drastically changes the human life. IoT envisions future in…”
    Get full text
    Journal Article
  5. 5

    Toward Intracellular Targeted Delivery of Cancer Therapeutics: Progress and Clinical Outlook for Brain Tumor Therapy by Pandya, Hetal, Debinski, Waldemar

    “…A number of anti-cancer drugs have their targets localized to particular intracellular compartments. These drugs reach the targets mainly through diffusion,…”
    Get full text
    Journal Article
  6. 6

    Toward Intracellular Targeted Delivery of Cancer Therapeutics: Progress and Clinical Outlook for Brain Tumor Therapy by Pandya, Hetal, Debinski, Waldemar

    “…A number of anti-cancer drugs have their targets localized to particular intracellular compartments. These drugs reach the targets mainly through diffusion,…”
    Get full text
    Journal Article
  7. 7
  8. 8

    An interleukin 13 receptor α 2-specific peptide homes to human Glioblastoma multiforme xenografts by Pandya, Hetal, Gibo, Denise M., Garg, Shivank, Kridel, Steven, Debinski, Waldemar

    Published in Neuro-oncology (Charlottesville, Va.) (01-01-2012)
    “…Interleukin 13 receptor α 2 (IL-13Rα2) is a glioblastoma multiforme (GBM)-associated plasma membrane receptor, a brain tumor of dismal prognosis. Here, we…”
    Get full text
    Journal Article
  9. 9

    Toward Intracellular Targeted Delivery of Cancer Therapeutics by Pandya, Hetal, Debinski, Waldemar

    “…A number of anti-cancer drugs have their targets localized to particular intracellular compartments. These drugs reach the targets mainly through diffusion,…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Abstract 5519: Development of ‘multiple-specificity’ vectors for targeted delivery to intracellular organelles of the glioblastoma multiforme tumor cells by Pandya, Hetal, Gibo, Denise, Debinski, Waldemar

    Published in Cancer research (Chicago, Ill.) (15-04-2010)
    “…Abstract Most anti-cancer therapeutics have defined targets such as proteins, enzymes or DNA which are localized in distinct intra-cellular compartments like…”
    Get full text
    Journal Article
  12. 12

    Abstract 5029: Microglia differentiated from induced pluripotent stem cells treat glioma tumors in mice by Pandya, Hetal, Ichikawa, David M., Shen, Michael J., Sedlock, Andrea B., Johnson, Kory R., Maric, Dragan, McGavern, Dorian B., Malech, Harry L., Park, John K.

    Published in Cancer research (Chicago, Ill.) (01-08-2015)
    “…Abstract Glioblastoma Multiforme (GBM), a grade IV astrocytoma is the most aggressive primary brain tumor. GBM patients have the worst prognoses with median…”
    Get full text
    Journal Article
  13. 13

    Abstract 4141: A heptapeptide specific for Interleukin 13 receptor alpha 2 homes to the receptor-positive human GBM xenografts by Pandya, Hetal, Garg, Shivank, Gibo, Denise M., Kridel, Steven J., Debinski, Waldemar

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…Abstract Introduction: One of our goals is to identify specific therapeutic delivery and imaging agents for Glioblastoma multiforme (GBM), a malignant primary…”
    Get full text
    Journal Article
  14. 14

    Intra-atrial tumour thrombus secondary to hepatocellular carcinoma by Pandya, Hetal, Shah, Chaitri, Lakhani, Jitendra, Patel, Micky

    Published in Australasian medical journal (01-01-2013)
    “…Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality. Hepatitis B & C accounts for most HCC occurrences. It is very rare to…”
    Get full text
    Journal Article
  15. 15

    Selection/construction and characterization of novel peptide and recombinant protein agents targeting interleukin 13 receptor alpha 2 in glioblastoma multiforme by Pandya, Hetal

    Published 2011
    “…Glioblastoma multiforme (GBM) is a primary brain tumor of dismal prognosis. Patients with GBM have a median survival rate of 14.5 months inspite of…”
    Get full text
    Dissertation
  16. 16

    Rare case of dystrophia myotonica with mega cisterna magna by Pandya, Hetal, Lakhani, Jitendra, Mehta, Jigar, Dodhania, Jimmy

    Published in Australasian medical journal (01-01-2012)
    “…Myotonic dystrophy is also known as dystrophia myotonica (DM). The condition is composed of at least two clinical disorders with overlapping phenotypes and…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Molecular targeting of intracellular compartments specifically in cancer cells by Pandya, Hetal, Gibo, Denise M, Debinski, Waldemar

    Published in Genes & cancer (01-05-2010)
    “…We have implemented a strategy in which a genetically engineered, single-chain protein specifically recognizes cancer cells and is trafficked to a targeted…”
    Get full text
    Journal Article
  19. 19
  20. 20